Addex ADX48621 Positive Primate Parkinson’s Data
Addex Pharmaceuticals (SWISS: ADXN), the allosteric modulation company, announced that in a non-human primate model of Parkinson’s disease (PD) levodopa induced dyskinesia (LID), ADX48621 statistically and significantly inhibited LID.
The rest is here:
Addex ADX48621 Positive Primate Parkinson’s Data